TrialBritish journal of cancer2017

Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).

Francis Lévi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.